Please login to the form below

Not currently logged in
Email:
Password:

Lilly partners on antiplatelet programme

Eli Lilly and Daiichi Sankyo have announced a collaboration with Accumetrics to educate doctors about a test involving antiplatelet therapy

Eli Lilly and Company and Daiichi Sankyo, its development and marketing partner on the antiplatelet medication Effient (prasugrel), have entered into a US collaboration with the diagnostics company Accumetrics to educate doctors about a rapid test that assesses patients' response to antiplatelet therapy.

The campaign comes on the heels of a clinical alert issued last month by the American College of Cardiology Foundation and American Heart Association in response to the addition of a boxed warning to the blockbuster antiplatelet therapy Plavix (clopidogrel bisulfate), which is marketed by sanofi-aventis (SA) and Bristol-Myers Squibb (BMS).

The warning states that due to genetic factors, some patients taking Plavix may have an increased risk of thrombotic cardiovascular events and some may have reduced response to the drug; the medical societies' alert stressed the variability in response in patients with acute coronary syndrome who are managed with the angioplasty and stenting technique known as PCI.

At the time, Lilly stressed that the genetic variation that complicated response to Plavix did not have the same effect for Effient, a difference that could give the Lilly drug an edge in the marketplace.

The new partnership promotes Accumetrics' point-of-care VerifyNow System as a way for doctors to determine patients' response to antiplatelet agents, including Plavix, Effient and others. The programme will educate doctors about the factors that affect response to antiplatelet medication and how platelet function testing works.

13th July 2010

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...

Infographics